- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
iScribe and insurance firm reduce rates for docs
iScribe and insurance firm reduce rates for docsIn one of the more unpredictable alliances resulting from the Institute of Medicine report on medical errors, San Mateo, CA-based iScribe has closed an agreement with The Doctors’ Company
iScribe and insurance firm reduce rates for docs
In one of the more unpredictable alliances resulting from the Institute of Medicine report on medical errors, San Mateo, CA-based iScribe has closed an agreement with The Doctors Company whereby TDC will reduce malpractice premiums for physicians who use the iScribe prescription-writing system. The Napa, CA-based insurer plans to offer the incentive initially to physicians writing the highest number of prescriptions. iScribe will provide its handheld prescription-writing system to physicians on TDCs plan free of charge starting in the third quarter of 2000. iScribes prescription-writing software checks for drug interactions and formulary information and automatically updates the prescription database (HNN 5/3/00).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
